Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
Guidelines for reporting artificial intelligence studies in medicines, pharmacotherapy, and pharmaceutical services: Medin AI development, validation and statement
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting AI studies in medicines, pharmacotherapy, and pharmaceutical services |
| Full bibliographic reference | Bottacin WE, Teles de Souza R, Torelli Reis WC, Carolina Melchiors A. Guidelines for reporting artificial intelligence studies in medicines, pharmacotherapy, and pharmaceutical services: MedinAI development, validation and statement. Int J Clin Pharm. 2025; 47: 945-956. |
| Date of publication / Ahead of print date | 2025 |
| Language | English |
| DOI | 10.1007/s11096-025-01905-3 |
| PubMed ID | 40202573 |
| Relevant URLs (full-text if available) |
Read the full text of MedinAI. The MedinAI checklist is available in the supplementary material. Read the full text of the Explanation and Elaboration. |
| Explanation and elaboration papers | Bottacin WE, Teles de Souza R, Torelli Reis WC, Carolina Melchiors A.Explanation and elaboration of MedinAI: guidelines for reporting artificial intelligence studies in medicines, pharmacotherapy, and pharmaceutical services. Int J Clin Pharm. 2025. |
| Reporting guideline acronym | MedinAI |
| Study design | Artificial intelligence/Machine learning studies |
| Record last updated on | September 10, 2025 |